David Dolling

6.6k total citations
27 papers, 579 citations indexed

About

David Dolling is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Cancer Research. According to data from OpenAlex, David Dolling has authored 27 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Infectious Diseases and 8 papers in Cancer Research. Recurrent topics in David Dolling's work include Prostate Cancer Treatment and Research (11 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (6 papers). David Dolling is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (6 papers). David Dolling collaborates with scholars based in United Kingdom, Spain and United States. David Dolling's co-authors include Johann S. de Bono, Diletta Bianchini, George Seed, Mateus Crespo, David Lorente, Mitzy Gafos, Anthony Nardone, Monica Desai, David Dunn and Leon W.M.M. Terstappen and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and BMJ.

In The Last Decade

David Dolling

24 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dolling United Kingdom 13 235 178 167 165 113 27 579
Jimmy Hwang United States 14 76 0.3× 60 0.3× 144 0.9× 124 0.8× 182 1.6× 26 631
Jodi Weidler United States 17 99 0.4× 107 0.6× 350 2.1× 188 1.1× 136 1.2× 43 624
San-San Ou United States 10 673 2.9× 386 2.2× 257 1.5× 107 0.6× 526 4.7× 11 973
Siddharth Sheth United States 16 117 0.5× 61 0.3× 260 1.6× 74 0.4× 123 1.1× 60 607
Graziella Becker‐Pergola United States 14 68 0.3× 169 0.9× 243 1.5× 368 2.2× 92 0.8× 18 708
Sairy Hernandez United States 12 103 0.4× 99 0.6× 317 1.9× 77 0.5× 106 0.9× 25 704
Franchette van den Berkmortel Netherlands 10 174 0.7× 184 1.0× 296 1.8× 125 0.8× 49 0.4× 22 587
Steven G. Roberts United States 9 345 1.5× 47 0.3× 51 0.3× 42 0.3× 107 0.9× 12 566
Erin R. King United States 10 123 0.5× 82 0.5× 98 0.6× 57 0.3× 160 1.4× 17 488
Nathan Winslow Spain 3 86 0.4× 35 0.2× 196 1.2× 78 0.5× 35 0.3× 3 368

Countries citing papers authored by David Dolling

Since Specialization
Citations

This map shows the geographic impact of David Dolling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dolling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dolling more than expected).

Fields of papers citing papers by David Dolling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dolling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dolling. The network helps show where David Dolling may publish in the future.

Co-authorship network of co-authors of David Dolling

This figure shows the co-authorship network connecting the top 25 collaborators of David Dolling. A scholar is included among the top collaborators of David Dolling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dolling. David Dolling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Dearbhaile Catherine, Raghav Sundar, Anastasia Constantinidou, et al.. (2021). Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease. BMC Cancer. 21(1). 245–245.
2.
Lu, Changxue, Angelika Terbuch, David Dolling, et al.. (2020). Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype. Annals of Oncology. 31(9). 1178–1185. 32 indexed citations
3.
Collins, Dearbhaile Catherine, Raghav Sundar, Anastasia Constantinidou, et al.. (2020). Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease. BMC Cancer. 20(1). 1210–1210. 11 indexed citations
4.
Winfield, Jessica, David Dolling, Marcia Hall, et al.. (2019). Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker. Radiology. 293(2). 374–383. 24 indexed citations
5.
Paschalis, Alec, Beshara Sheehan, Ruth Riisnaes, et al.. (2019). PSMA heterogeneity and DNA repair defects in prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5002–5002. 1 indexed citations
6.
Sundar, Raghav, Terri McVeigh, David Dolling, et al.. (2018). Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials. European Journal of Cancer. 101. 55–61. 6 indexed citations
7.
Mehra, Niven, David Dolling, Semini Sumanasuriya, et al.. (2018). Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA). European Urology. 74(3). 283–291. 78 indexed citations
8.
Rescigno, Pasquale, David Lorente, David Dolling, et al.. (2018). Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers. European Urology Oncology. 1(1). 71–77. 27 indexed citations
9.
Nanou, Afroditi, Frank Coumans, Guus van Dalum, et al.. (2018). Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients. Oncotarget. 9(27). 19283–19293. 54 indexed citations
10.
Garces, Alvaro Ingles, Joo Ern Ang, Malaka Ameratunga, et al.. (2018). A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials. European Journal of Cancer. 104. 32–38. 14 indexed citations
11.
Lorente, David, David Olmos, Joaquı́n Mateo, et al.. (2018). Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts. Annals of Oncology. 29(7). 1554–1560. 72 indexed citations
12.
Barrero, Maialen, Mattia Rediti, Mateus Crespo, et al.. (2018). Tumor-infiltrating lymphocytes in biallelic-CDK12 mutated prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 5070–5070. 4 indexed citations
13.
Mehra, Niven, Adam Sharp, David Lorente, et al.. (2017). Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids. Clinical Genitourinary Cancer. 15(6). 678–684.e1. 16 indexed citations
14.
Ameratunga, Malaka, Maxime Chénard-Poirier, Andrew Lui, et al.. (2017). Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors. European Journal of Cancer. 89. 56–63. 54 indexed citations
15.
Dolling, David, Ruth Goodall, M. Chirara, et al.. (2017). The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data. BMC Infectious Diseases. 17(1). 160–160. 3 indexed citations
16.
Gafos, Mitzy, David Dolling, Monica Desai, et al.. (2014). Sexual Behaviour Profile of Gay and Other Men Who Have Sex with Men Enrolled in the PROUD Pre-exposure Prophylaxis Open-label Pilot Study in England. AIDS Research and Human Retroviruses. 30(S1). A22–A22.
17.
Hué, Stéphane, Alison Brown, Manon Ragonnet‐Cronin, et al.. (2014). Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions. AIDS. 28(13). 1967–1975. 53 indexed citations
18.
Dolling, David, David Dunn, Deenan Pillay, et al.. (2013). Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study. Journal of Antimicrobial Chemotherapy. 68(10). 2339–43. 11 indexed citations
19.
20.
Dolling, David. (2012). Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ. 345(aug21 2). e5253–e5253. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jimmy Hwang Breakdown of academic impact, for papers by Jodi Weidler Breakdown of academic impact, for papers by San-San Ou Breakdown of academic impact, for papers by Siddharth Sheth Breakdown of academic impact, for papers by Graziella Becker‐Pergola Breakdown of academic impact, for papers by Sairy Hernandez Breakdown of academic impact, for papers by Franchette van den Berkmortel Breakdown of academic impact, for papers by Steven G. Roberts Breakdown of academic impact, for papers by Erin R. King Breakdown of academic impact, for papers by Nathan Winslow
Rankless by CCL
2026